Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan

SUMMARY: Among hypothetical cohorts of older osteoporotic women without prior fragility fracture in Japan, we evaluated the cost-effectiveness of two treatment strategies using a simulation model. Annual intravenous zoledronic acid for 3 years was cost-saving compared with biannual subcutaneous deno...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Takahiro, Crandall, Carolyn J., Fujii, Tomoko, Ganz, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282566/
https://www.ncbi.nlm.nih.gov/pubmed/34264429
http://dx.doi.org/10.1007/s11657-021-00956-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282566/
https://www.ncbi.nlm.nih.gov/pubmed/34264429
http://dx.doi.org/10.1007/s11657-021-00956-z

Ejemplares similares